Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
Clinical trial NCT04823702 · COMPLETED
Trial details
- NCT number
- NCT04823702
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2021-11-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.